Summary
Bone marrow transplantation is the therapy of choice in patients affected by MPS I (Hurler syndrome), but a high incidence of rejection limits the success of this treatment. The deficiency of α-L-iduronidase (EC 1.2.3.76), one of the enzymes responsible for the degradation of glycosaminoglycans, results in accumulation of heparan and dermatan sulphate in these patients. Heparan sulphate and dermatan sulphate are known to be important components of the bone marrow microenvironment and critical for haematopoietic cell development. In this study we compared the ability of marrow stromal cells from MPS I patients and healthy donors to support normal haematopoiesis in Dexter-type long term culture. We found an inverse stroma/supernatant ratio in the number of clonogenic progenitors, particularly the colony-forming unit granulocyte–machrophage in MPS I cultures when compared to normal controls. No alteration in the adhesion of haematopoietic cells to the stroma of MPS I patients was found, suggesting that the altered distribution in the number of clonogenic progenitors is probably the result of an accelerated process of differentiation and maturation. The use of α-L-iduronidase gene-corrected marrow stromal cells re-established normal haematopoiesis in culture, suggesting that correction of the bone marrow microenvironment with competent enzyme prior to transplantation might help establishment of donor haematopoiesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baxter MA, Wynn RF, Deakin JA, et al (2002) Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. Blood 99: 1857–1859.
Bianco P, Gehron Robey P (2000) Marrow stromal stem cells. J Clin Invest 105: 1663–1668.
Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278–294.
Calvi LM, Adams GB, Weibrecht KW, et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841–846.
Campagnoli C, Bellantuono I, Kumar S, Fairbairn LJ, Roberts I, Fisk NM (2002) High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy. BJOG 109: 952–954.
Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396–2402.
Clark BR, Gallagher JT, Dexter TM (1992) Cell adhesion in the stromal regulation of haematopoiesis. Baillières Clin Haematol 5: 619–652.
Fairbairn LJ, Lashford LS, Spooncer E, et al (1996) Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Proc Natl Acad Sci USA 93: 2025–2030.
Gordon MY, Lewis JL, Grand FH, Marley SB, Goldman JM (1996) Phenotype and progeny of primitive adherent human hematopoietic progenitors. Leukemia 10: 1347–1353.
Gupta P, Oegema TR Jr, Brazil JJ, Dudek AZ, Slungaard A, Verfaillie CM (2000) Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95: 147–155.
Hinek A, Wilson SE (2000) Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. Am J Pathol 156: 925–938.
Hobbs JR, Hugh-Jones K, Barrett AJ, et al (1981) Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2: 709–712.
Hofling AA, Vogler C, Creer MH, Sands MS (2003) Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease. Blood 101: 2054–2063.
Hurley RW, McCarthy JB, Verfaillie CM (1995) Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96: 511–519.
Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL (2000) Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol 165: 1599–1604.
Na Nakorn T, Traver D, Weissman IL, Akashi K (2002) Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 109: 1579–1585.
Nuttall JD, Brumfield LK, Fazzalari NL, Hopwood JJ, Byers S (1999) Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI. Calcif Tissue Int 65: 47–52.
Pan C, Nelson MS, Reyes M, et al (2005) Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biological activity of FGF-2 on human multipotent progenitor cells. Blood 106(6): 1956–1964.
Peters C, Balthazor M, Shapiro EG, et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87: 4894–4902.
Peters C, Shapiro EG, Anderson J, et al (1998) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 91: 2601–2608.
Pittenger MF, Mackay AM, Beck SC, et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71–74.
Ramsay SL, Meikle PJ, Hopwood JJ (2003) Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry. Mol Genet Metab 78: 193–204.
Siczkowski M, Clarke D, Gordon MY (1992) Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 80: 912–919.
Termeer CC, Hennies J, Voith U, et al (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165: 1863–1870.
Toogood IR, Dexter TM, Allen TD, Suda T, Lajtha LG (1980) The development of a liquid culture system for the growth of human bone marrow. Leuk Res 4: 449–461.
Vellodi A, Young EP, Cooper A, et al (1997) Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76: 92–99.
Verfaillie CM, Benis A, Iida J, McGlave PB, McCarthy JB (1994) Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84: 1802–1811.
Whitley CB, Ramsay NK, Kersey JH, Krivit W (1986) Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. Birth Defects Orig Artic Ser 22: 7–24.
Zhang J, Niu C, Ye L, et al (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836–841.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baxter, M.A., Wynn, R.F., Schyma, L. et al. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development. J Inherit Metab Dis 28, 1045–1053 (2005). https://doi.org/10.1007/s10545-005-0136-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0136-4